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Abstract:  
         This study was established to evaluate and monitor both the humoral and haematological 
responses to Fascioliasis and its treatment in rabbit model. Rabbits were orally inoculated with 
viable F. gigantica metacercariae and then divided into four groups. Infected rabbits were orally 
administered a single dose of Triclabendazole (TCBZ) (10 mg kg
-1) at week 4, 8 or 12 post-
infection  (pi),  respectively.  Antibody  (Ab)  response  against  infection  was  monitored  using 
enzyme linked immunosorbant assay (ELISA). Total red blood cell counts (Rbcs), haemoglobin 
content (Hb) and total and differential white blood cells (Wbcs) were also determined. Infected 
rabbits were found to produce Ab against excretory-secretory products (ESP) of adult flukes 
two weeks pi where ELISA enabled the early diagnosis of infection. Ab level reached to the 
peak at week 10 pi. In TCBZ-treated groups, the early Ab responses prior to treatments were 
similar  to  response  of  infected-untreated  rabbits.  But,  after  different  treatment  regimens,  Ab 
levels  showed  a  significant  decreases  that  were  depended  mainly  on  both  time  and  hence 
efficacy  of  the  treatment.  In  addition,  significant  reductions  in  both  Rbcs  and  Hb  values 
accompanied  with  mild  anemia  were  found  among  infected  group  at  week  12  &10  pi, 
respectively.  TCBZ-treatment  prevented  the  development  of  anaemia.  Eosinophil  numbers 
significantly increased starting from week 2 pi and peaking  at week 4 or 6 pi in all groups. 
Hence,  both  eosniophilia  and  anaemia  might  be  characteristic  aspects  for  experimental 
fascioliasis.  
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Introduction 
         Fascioliasis is a well-known parasitic 
disease because of its veterinary importance 
and  the  great  losses  it  causes  in  livestock 
production  (Mas-Coma  &  Bargues  1997). 
Fascioliasis is also now an important human 
parasitic  disease,  with  estimated  ranging 
from  2.4  to  17  million  people  infected. 
(Mas-Coma  et  al.,  1999).  The  number  of 
cases  of  human  fascioliasis  reported  in 
Egypt  has  increased  drastically  during  the 
past years (Curtale et al., 2003).  
         At present, it is essential that methods 
to  control  the  disease  involve  a  chemothe-
rapeutic  strategy  based  on  epidemiological 
knowledge.  It  is  therefore  necessary  to 
develop methods for early diagnosis and to 
assay  drugs  which  are  effective  against 
developmental stage of Fasciola (Martinez, 
et al., 1997). In this regards, large numbers 
of  fasciolicides  are  available  and  used 
successfully allover the world. According to 
WHO  (1998),  Triclabendazole  (TCBZ),  a 
benzimidazole  compound,  has  recently 
been  registered  in  Egypt  for  the  treatment 
of human fascioliasis. TCBZ has been used 
in  veterinary  practice  for  fascioliasis  since 
1983.  However,  time  was  not  too  far  to 
recognized that TCBZ resistant liver flukes 
generated in buffaloes would be transmitted 
to other ruminant species as well as human 
(Sanyal, 1998).  
         Many  literatures  have  been  cited 
about  the  role  of  enzyme-linked  immunos-
orbent assay (ELISA) in diagnostic purpose 
for  fascioliasis  (Levine  et  al.,  1980, 
Cornelissen  et  al.,  1992;  Guobadia  & 
Fagbemi, 1996; Martinez et al., 1996). On 
the  other  hand,  little  is  known  about  the 
various  mechanisms  of  immunomodulation 
that  occur  either  during  fascioliasis  or 
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during  disease  treatment  compared  to 
informations  available  for  other  trematode 
infections  like  Schistosoma  (Poitou  et  al., 
1992; Martinez et al., 1997).  
         A  broad  spectrum  of  mammalian 
species especially herbivorous animals may 
serve as experimental hosts for the common 
liver  flukes,  Fasciola  sp.  Establishment  of 
F.  gigantica  infection  in  the  laboratory 
animals  has  been  previously  reported  in 
mice  (Yoshihara  &  Suzuki,  1990),  in  rat 
(Yoshioka,  1991),  in  guinea  pig  (EL-
Shaieb, 1995) and in rabbit (Abou-Basha et 
al., 1983; Desoky, 1985, Gupta & Yadav, 
1995; El-Bahy, 1997, Abdel-Rahman et al., 
1997;  El-Sayed,  1997;  Helal  et  al.,  2000; 
Abdel-Rahman  &  Abdel-Megeed,  2004).  
In  this  regard,  El-Bahy  (1997)  suggested 
that  the  best  condition  for  production  of 
mature F. gigantica worm in rabbit depends 
mainly on the dose of metacercariae and the 
general health conditions of the rabbit. 
         The present work was established for 
supporting  the  studies  required  for 
diagnosis  and  control  of  fascioliasis.  The 
humoral  and  haematological  responses  to 
experimental  fascioliasis  alone  and 
combined  with  the  chemotherapy  (TCBZ) 
in rabbit model were monitored.  
 
Material and methods 
Animals & Experimental Infection 
         Twenty five rabbits (approximately, 2 
- 2.5 kg) were used for the establishment of 
F.  gigantica  infection.  The  rabbits  were 
kept  in  clean  metal  cages  and  fed  on 
balanced  ration  and  water  ad-libitum.  The 
rabbits  were  healthy  and  free  from  
parasites  and  infectious  diseases  as 
indicated  by  the  absence  of  clinical  signs 
and by performing blood analysis as well as 
the  daily  faecal  examination  for  10  days 
using  the  simple  sedimentation  technique 
(Faust, et  al., 1939).  Twenty rabbits  were 
orally  inoculated  with  25  ±  5  viable  F. 
gigantica  metacercariae  (age:  10-15  days) 
per  animal;  the  viability  of  metacercariae 
were  determined  by  the  refractile 
appearance  of  the  excretory  granules 
(Boray,  1969)  and  the  movement  of 
juveniles  within  the  cysts.  The  remaining 
five  rabbits  were  served  as  control  group 
(A).  
Treatment Regimens  
Infected  rabbits  were  randomly 
allocated  in  four  groups  of  five  animals 
each  (groups  B,  C,  D  &  E).  Group  B 
remained  infected  and  did  not  receive 
treatment.  At  weeks  4,  8  and  12  post 
infection  (pi),  TCBZ  was  administered  to 
groups  C,  D  and  E,  respectively.  TCBZ 
(FASINEX:    CIBA-GEIGY,  Switzerland) 
was  orally  administered  as  a  single 
therapeutic  dose  of  10  mg  kg
-1  in  distilled 
water. The dose was calculated according to 
Paget & Barnes (1964).  
Blood Sampling: 
         Blood  samples  were  taken  from  the 
eye  of  all  rabbits  by  using  orbital  sinus 
technique (Sanford, 1954) at weeks 0, 2, 4 
6, 8, 10, 12, 14, and 16 pi. Blood samples 
were  collected  into  tubes  containing  the 
anticoagulant  (Ethylene  -  Diamine  Tetra  – 
Acetate, EDTA) at the rate of 2 mg/ml of 
blood  (Hawk  et  al.,  1965)  for  haema-
tological  analysis  and  also  into  tubes 
without  anticoagulant  for  preparation  of 
sera and serological analysis. Obtained sera 
were stored at -20
oc till used in antibodies 
assay.  
 
F.  gigantica  Excretory  –  Secretory 
Product (ESP) (Antigen Preparation): 
         ESP  antigen  was  prepared  according 
to Rivert Marrero et al. (1988). Flukes were 
collected from cattle bile ducts and washed 
several times in 0.01 M phosphate buffered 
saline (PBS), pH 7.4 and then incubated in 
PBS at 37
 oC for 3 hrs; one worm/ 5 ml in 
PBS.  The  flukes  were  removed  and  the 
supernatant  fluid  (PBS  +  ESP)  was 
centrifuged at (12, 000 rpm) for 1 hr at 4
oc. 
The  supernatant  was  separated  and 
designated  as  ESP  antigen.  The  protein 
content  was  determined  by  Biomeriux  kit 
(laboratory reagent and instrument, France) 
according  to  Lowry  et  al.  (1951).  The 
antigen was aliquoted and stored at –70
 oC 
until used. 
Enzyme  Linked  Immunosorbant  Assay 
(ELISA): 
         Specific  antibodies  against  F. 
gigantica  ESP  antigen  were  determined 
during infection and treatment using ELISA 
(Oldham,  1983).  Microtiter  plate  (Nunc) 
was coated with 100 µl ESP antigen (5 µg Serological And Haematological Responses To………. 
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protein  /ml)  in  coating  buffer  (0.05  M 
carbonate  buffer,  pH  9.6)  and  incubated 
overnight at 4
oC. The plates were washed in 
PBS – Tween (PBS—T) – 20 (0.05 %) then 
200  µl/  well  of  blocking  buffer,  0.1% 
bovine  serum  albumin,  (BSA)  was  added 
and incubated for 1 hr at 37
 oC. 100 µl of 
serum of all experimental groups diluted at 
1:100 in PBS-T were added and incubated 
for 1hr at room temperature. After washing, 
100 µl / well of the conjugate, Horseradish 
peroxidase conjugated goat anti rabbit IgG 
(whole  molecule)  (Sigma  Immunoc-
hemicals)  was  added  1:2000  dilution  in 
PBS-–  T  0.05%  (were  added).  The  plates 
were  incubated  for  1hr  at  37
oC.  After 
washing,  substrate,  Ortho–phenylenediam-
idine (Sigma Immunochemicals) at 100 µl / 
well  and  incubated  for  5  minutes  at  room 
temperature.  The  reaction  was  stopped  by 
adding  100  µl  /  well  of  1  M  H2SO4.  The 
optical  density  (OD)  was  read  using 
spectrophotometer  (Titertek  –  multiscan, 
Mcc  photometer  {Flow  Lab,  Mclean, 
Virginia} at 492 nm.  
Haematological parameters: 
         The  total  red  blood  cells  (Rbcs)  and 
white blood cells (Wbcs) were counted per 
µl  of  blood  by  Neubauer  double 
haemocytometer  according  to  Miller  & 
Seward  (1971).  The  blood  haemoglobin 
(Hb)  and  differential  Wbcs  counts  were 
determined according to Jain (1986).  
Flukes Recovery and Drug Efficacy: 
         At week 16 pi, all infected and treated 
rabbits  were  sacrificed  and  dissected. 
Flukes  were  recovered  according  to  the 
method  of  Kendall  et  al.  (1967)  where 
livers  and  gall  bladders  were  examined 
carefully  for  flukes;  all  recovered  flukes 
were  collected  and  counted.  The 
anthelmintic  efficacy  of  each  drug  was 
expressed  as  percentage  reduction  of  the 
number of flukes in the treated groups when 
compared with the untreated control group, 
according to the  following formula:  (Mean 
number  flukes  in  control  group)  –  (Mean 
number of flukes in treated group) / (Mean 
number flukes in control group) X100. 
Histological examination 
         Specimen  of  infected  liver  were 
removed out from scarified rabbits, fixed in 
10%  buffered  formalin,  embedded  in 
paraffin,  sectioned  at  5  m  thickness  and 
stained with  H&E. 
Statistical analysis 
         All  data  were  conducted  with  the 
software packages Microsoft SPSS version 
11.0,  for  statistical  evaluation.  Data  were 
presented as means ± SE. A student’s t-test 
and  one  way  analysis  of  variance 
(ANOVA) were used. 
 
Results 
         Monitoring of  Ab  response  in  all  the 
experimental groups using ELISA is shown 
in  Fig  (1).  In  infected-untreated  rabbits, 
group (B), Ab level began to rise above the 
levels of non-infected group (A) 2-week pi 
(p < 0.01). After that there was a significant 
increase in Ab level, reaching to the peak at 
week  10  pi.  Ab  level  showed  a  slight 
decrease at the end of the experiment (week 
16 pi). 
         In  TCBZ-treated  groups  (C-E),  the 
early  antibody  response  before  treatment 
was similar to that of group B. The peak of 
Ab levels of group C, treated at week 4 pi, 
was recorded at week 6 pi and after that the 
level remained nearly constant till week 12 
pi followed by significant decrease at weeks 
16  pi  compared  to  level  of    group  B  (p 
<0.001).  At  this  time  Ab  level  was  still 
above  level  of  non-infected  rabbits  (p  < 
0.001).  Ab  level  reached  to  the  peak  at 
weeks  10  &  12  pi  in  groups  D  &  E, 
respectively. Ab levels showed a significant 
decrease  6  &  2  weeks  post-  treatment  in 
groups D and E, respectively. At week 16, 
Ab  level  of  groups  D  and  E  was 
significantly lower than level of group B (p 
<  0.001),  but  still  exceed  levels  of  pre-
infection  (P  <  0.001).  At  week  16  pi,  a 
significant  difference  in  the  Ab  levels  was 
found between groups D and E (P <0.05). 
         Monitoring  the  changes  in  Rbcs,  Hb 
in  all  groups  throughout  the  time  of 
experiment  is  shown  in  figures  (2  &  3). 
Remarkable decrease in both Rbcs and Hb 
values  (mild  anaemia)  of  infected  rabbits 
(group (B) were found at weeks 12 & 10 pi, 
respectively,  when  compared  to  non-
infected group A (p < 0.01). This decrease 
extended  to  week  16  pi  (p  <0.001).  In 
TCBZ-treated groups (C & D), Rbcs & Hb 
values were within the normal range. While Nour El Din H. Sherif et al  
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in  group  E,  a  significant  decrease  below 
normal range was found starting from week 
14  and  12  pi  in  Rbcs  &  Hb  values, 
respectively (p < 0.01; p < 0.001). 
Concerning the total Wbcs count, it 
was  within  the  normal  levels  in  all 
experimental  groups.  But,  only  the 
eosinophils showed a significant increase 2-
weeks  pi,  peaked  at  weeks  4  or  6  pi  and 
followed  by  significant  decrease  in  their 
number;  although  it  was  still  above  the 
normal  levels  (Fig.  4).  No  changes  were 
recorded  in  the  number  of  neutrophils, 
basophils,  monocytes  and  lymphocytes; 
they were all around the normal values.  
Regarding  to  TCBZ  efficacy,  our 
results  showed  that  TCBZ  was  highly 
efficient  in  eliminating    the  flukes  and  its 
efficacy  was  dependent  on  time  of 
administration. The efficacy was 93.75  %, 
100% & 100% for groups treated at weeks 
4,  8  &  12  pi,  respectively.  Figure  (1) 
showed Fasciola gigantica worm resided in 
the bile ducts of an infected rabbit. 
 
Table 1: Antibody Levels (Measured By ELISA) against F. gigantica ESP antigen during 
experimental fascioliasis and TCBZ-Treatment. Absorbance at 492 nm. 
Results are given as mean ± SE. A: Group A: Non-infected; B: Infected-untreated; C:  Infected-
treated- 8 weeks pi; D: Infected-treated- 4 weeks pi; E: Infected-treated- 12 weeks pi. 
 
Table 2: Changes in RBCs (x10
6/mm
3) count during Fascioliasis and TCBZ- Treatment.  
 
Results are given as mean ± SE. A: Group A: Non-infected; B: Infected-untreated; C:  Infected-
treated- 8 weeks pi; D: Infected-treated- 4 weeks pi; E: Infected-treated- 12 weeks pi. 
Weeks pi  Group A  Group B  Group C  Group D  Group E 
0  0.13 ± 0.03  0.13 ± 0.04  0.4 ± 0.03  0.153 ± 0.02  0.131± 0.03 
2  0.16 ± 0.03  0.217 ± 0.01  0.238 ± 0.02  0.226 ± 0.02  0.23 ± 0.03 
4  0.14 ± 0.03  0.33 ± 0.2  0.33 ± 0.02  0.32 ± 0.03  0.32 ± 0.03 
6  0.13 ± 0.04  0.364 ± 0.03  0.364 ± 0.03  0.39 ± 0.02  0.372 ± 0.02 
8  0.14 ± 0.04  0.387 ± 0.02  0.39 ± 0.02  0.421 ± 0.02  0.366 ± 0.02 
10  0.153 ± 0.02  0.485 ± 0.04  0.47 ± 0.03  0.49 ± 0.02  0.36 ± 0.04 
12  0.13 ± 0.04  0.463 ± 0.03  0.484 ± 0.04  0.433 ± 0.05  0.0.33 ± 0.03 
14  0.152 ± 0.02  0.412 ± 0.2  0.392 ± 0.02  0.254 ± 0.01  0.273 ± 0.03 
16  0.14 ± 0.03  0.385 ± 0.02  0.272 ± 0.04  0.215 ± 0.02  0.266 ± 0.05 
Weeks 
pi  Group A  Group B  Group C  Group D  Group E 
0  4.53±0.2  4.33±0.2  4.6±0.9  4.48±0.1  4.97±0.3 
2  4.35±0.2  4.33±0.3  4.45±0.2  4.45±0.5  4.47±0.3 
4  4.35±0.3  4.45±0.1  4.45±0.5  4.4±0.2  4.7±0.1 
6  4.25±0.3  4.23±0.3  4.2±0.2  4.1±0.4  4.25±0.2 
8  4.05±0.3  4.08±0.1  4.35±0.3  4.48±0.2  4.38±0.3 
10  3.73±0.2  3.75±0.2  4.33±0.3  4.18±0.3  4.38±0.2 
12  3.6±0.2  3.72±0.2  3.88±0.3  3.55±0.1  4.4.1±0.3 
14  3.48±0.2  3.83±0.3  3.9±0.2  3.4±0.3  4.55±0.2 
16  3.43±0.2  3.75±0.1  4.13±0.5  3.15±0.3  4.13±0.5 Serological And Haematological Responses To………. 
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Table    3:  Changes  in  HB  (g  %)  content  during  experimental  Fascioliasis  and  TCBZ- 
Treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results are given as mean ± SE. A:  Group A: Non-infected; B: Infected-untreated; C:   Infected-
treated- 8 weeks pi; D: Infected-treated- 4 weeks pi; E: Infected-treated- 12 weeks pi. 
 
Table 4: Changes  in number of  eosinophils during experimental  Fascioliasis and  TCBZ- 
Treatment.  
 
Results are given as mean ± SE. A:  Group A: Non-infected; B: Infected-untreated; C:   Infected-
treated- 8 weeks pi; D: Infected-treated- 4 weeks pi; E: Infected-treated- 12 weeks pi. 
 
 
 
 
Fig 1 (A): Liver section  of rabbit experimentally infected  with  F. gigantica showing  the 
worm resided in the bile ducts. F: fluke; bd: bile duct; hc: hepatic cells; t tegument 
of worm (x100). (B): enlarged liver section (x200). 
Weeks 
pi  Group A  Group B  Group C  Group D  Group E 
 
0  10.78±0.8  11±0.4  10.65±0.5  11.38±1.0  10.9±0.1 
2  10.75±0.4  11.28±0.9  10.55±0.6  10.63±1.3  10.8±0.5 
4  10.75±0.6  10.95±0.5  10.68±0.7  11.1±0.9  10.93±0.9 
6  10.35±0.7  10.73±0.6  10.98±0.9  10.83±1.3  10.78±0.9 
8  9.88±0.4  10.1±0.6  10.53±0.4  10.2±0.7  10.95±1.0 
10  9.38±0.2  9.43±0.4  10.3±0.4  9.28±0.3  10.6±0.7 
12  8.25±0.24  8.9±0.2  9.95±0.4  8.48±0.4  10.85±0.5 
14  8.45±0.2  9.35±0.2  10.1±0.4  8.4±0.1  10.28±0.5 
16  8.88±0.3  9.38±0.2  10.4±0.8  8.15±0.3  11.1±0.83 
Weeks 
pi  Group A  Group B  Group C  Group D  Group E 
0  3±2.0  3.1±1.2  2.3±1.3  2.5±1.2  3.5±1.7 
2  15.5±5.1  9.5±3.1  20±8  17±6.1  5±2.0 
4  35.5±4.7  25±7.8  31±10.6  33±7.7  2.1±1.4 
6  29±7.8  19±6.5  35±7.3  24±8  1.8±1.2 
8  11.5±4.4  18.5±7.5  14.5±5.2  10±3.9  4.8±2.5 
10  7.5±1.6  8±1.7  6.5±3  8±4.8  3.8±1.1 
12  11.3±3.0  10.5±3.3  6.5±6.5  6±2.1  5.5±2.2 
14  8.2±1.8  6.5±3.5  10.5±5.6  13.5±6.4  3.7±1.8 
16  12±2.4  9±3.7  7.3±1.7  9.5±1.1  2.5±1.9 Nour El Din H. Sherif et al  
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Discussion 
         Using  direct  ELISA  method,  Ab 
against ESP of adult F. gigantica was found 
early,  two  weeks  pi,  in  sera  of  the 
experimentally  infected  rabbits  where 
ELISA  enabled  the  early  diagnosis.  This 
method,  which  has  been  used  in  other 
infections,  showed  satisfactory  responses 
when  employed  in  this  study.  Antibody 
level  reached  peak  at  week  10  pi.  This 
antibody  response  was  similar  to  that 
described  for  the  primary  infection  with 
Fasciola sp.; in rat (Levine, et al.,  1980), 
sheep (Cornelissen et al., 1992; Chauvin et 
al., 1995), cattle (Boulard et al., 1995) in 
goats (Martinez et al., 1996) and rabbit (El 
Bahy,  1997).  On  the  other  hand,  the 
detection of antibodies by first week pi was 
recorded in rat (Yoshioka, 1991; Poitou, et 
al.,  1992)  and  in  sheep  (Guodadia  & 
Fagbemi  1996)  and  by  week  3  in  rabbit 
(Santiago et al., 1986) and rat (Keegan & 
Trudgett, 1992). Helal et al. (2001) found 
that Ab were detected in the sera of rabbits 
infected  with  F.  gigantica  at  6  week  pi 
against adult and metacercarial  antigen and 
at  weeks  9-10  pi  against  ESP  using  
precipitating  test.  Hence,  these  findings 
may confirm the advantage of using  direct 
ELISA methods. 
         Antibody peak observed in this study 
at  week  10  pi  indicated  that  there  is  a 
different  Ab  response  at  this  late  stage  of 
infection  compared  to  the  early  low 
response. In this regard, Poitou et al. (1992) 
pointed  out  that  the  antibody  response  is 
basically  directed  against  antigen 
determinants  of  high  molecular  weight, 
present both in the juvenile tegument and in 
ESP structure in the adult. However, Hillyer 
(1979)  found  that  ESP  appeared  more 
antigenic  than  tegument  antigen  using 
Eliza. This finding has been also supported 
by  Chauvin  et  al.  (1995),  who  suggested 
that the  production of antibody  appearing 
at  the  late  stage  of  infection  are  related 
specifically to the sequential release of ESP 
by adult flukes in bile ducts.  
         In  TCBZ-treated  groups,  the  early 
antibody responses were similar to those of 
infected-untreated  rabbits  followed  by 
significant decrease after treatment that was 
depended on both the  time and efficacy  of 
treatment.  These  findings  are  similar  to 
those of Levine et al. (1980) in rat, Hanna, 
et al. (1982) in sheep, Fetterer, et al. (1985) 
in cattle and Martinez et al. (1997) in goats.  
Fetterer,  et  al.  (1985)  suggested  that  the 
reduced  Ab  response  after  treatment  must 
be  expected  if  drug  treatment  kills  flukes 
while they are immature when antigen used 
in ELISA was prepared from adult flukes. 
In addition, it has been reported that when 
the  early  treatment  failed  to  achieve  total 
elimination  of  parasites,  the  post-peak 
decrease  was  marked  after  several  weeks 
post-treatment,  while,  in  goats  in  which 
treatment  totally  eliminated  the  parasite 
burden, Ab levels fell back very rapidly to 
negative values (Martinez et al., 1997). In 
contrary,  our  results  showed  that  although 
there  was  a  high  significant  drop  in  Ab 
levels  at  weeks  6  &  2  post  treatment  in 
groups  D  &  E,  respectively,  where  there 
was  total  elimination  of  flukes,  the  levels 
did not reach to negative values at all. The 
reason  of  this  variation  in  serological 
response  between  our  study  and  the  study 
of Martinez et al., (1997) may be related to 
the  difference  in  immune  response  of  the 
experimental  animals  used  which  could 
modify  the  mode  of  action  of  TCBZ 
treatment.  For  instance,  TCBZ  which  was 
able to eliminate the ESP of flukes in goats 
may not be able to have the same effect in 
rabbit.    However,  these  points  need  a 
further investigation. 
         The  current  study  showed  that 
experimental  fascioliasis  caused  a  mild 
anaemia  starting  from  weeks  10-12  pi  in 
untreated-infected  rabbits.  Since  at  weeks 
10  or  12,  usually  the  late  immature  or 
mature worms are found  in bile ducts,  the 
anemia  might  be  directly  related  to  the 
presence  of  worms  in  the  ducts  (Hawkins, 
1984  and  Martinez  et  al.,  1997).  In 
contrary,  Haroun,  et  al.  (1989)  found 
anemic  process  in  F.  gigantica-infected 
goats at the start of infection that coincided 
with  the  migration  of  immature  forms 
through the hepatic parenchyma. This study 
showed  that  TCBZ-treatment  resulted  in 
absence  of  anaemic  processes  when Serological And Haematological Responses To………. 
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treatment was applied early in groups C & 
D  with  94%  &  100%  fluke  eradication 
rates, respectively. Only in group E, treated 
at week 12 pi, anaemia was found but the 
improvement  may  be  expected  in  the 
followings  weeks.  However,  many  other 
factors  might  play  a  role  in  the  anemic 
process  during  fascioliasis  like  size  of  the 
fluke  burden  (Hawkins,  1984)  and  species 
of animals (Waweru et al., 1999).  
         Eosinophilia,  involved  in  hypersen-
sitivity  mechanisms  and  phagocytosis,  is  a 
feature  of  helminthes  infestation,  including 
Fasciola (Poitou et al., 1993 and Chauvin 
et  al.,  1995).  Accordingly,  a  monophasic 
eosinophilia with one peak at week 4 or 6 
was  found  in  all  infected  and  treated 
groups.  Chauvin  et  al.  (1995)  described  a 
biphasic  eosinophilia  with  two  peaks 
recorded  from  week  3-5  pi  followed  by 
drop  and  second  increase  from  week  9-11 
pi  in  F.  hepatica  infected  sheep.  In 
contrary, Martinez et al.,  (1997) reported 
that  the  leukocytes  number  were  highly 
variable and  no significant  difference  were 
detected  between  the  non-infected,  infected 
and  treated  goats  experimentally  infected 
with F. hepatica. However, we may suggest 
that both eosniophilia and anaemia might be 
characteristic  aspects  for  experimental 
fascioliasis.  
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تاباجتسا   اهجلاع و لاىيشافلاب ةباصلإا ىلع  ةيىمد و ةيجىلوريس  
 
 هيدلا رىو فيرش   - إ ىبلش ليعامس   –     ناميلس اهم -   هسح لامج دمحم  
 
ٌإيحنا ىهع ىسق -    وٕهعنا تيهك –   سيٕسنا ةاُق تعياج -    تيهيعاًسلإا –    شصي تيسًٕٓج
تيبشعنا 
  1     
    2      ثايهيفطنا ىسق –   ٖشطيبنا بطنا تيهك -   تعياج   سيٕسنا ةاُق -    تيهيعاًسلإا –  
تيبشعناشصي تيسًٕٓج 
 
ا ىيىياحٔ تىبقاشي جىًح جىساسذنا ِزىْ ٗىف لإ  تباىةبن  تىيٕيذنا ٔ تىيعاًُنا ثابااخىس
اىٓجلاع ٔ ًايهًعي لإيشافناب  .  اى يخَااياج لإيىشاف ثايساكشىساخيًب بىَاساا تباىةص جىًح
اي  ىبس  ٗىنص تباىصًنا بىَاساا جببعىشح كنر ذعبٔ ىفنا قيشط ٍع ثاىعًٕ  .   لاىع ىىح 3  
 سااع ٍي ىفنا قيشط ٍع ةذحأ تعشاب تباصًنا بَاساا ٍي ثاعًٕاي ح   لٔصاذُبلا يش
( 11   ىىىاك كىىي
- 1   (   يباىىساا تىىياذب ٗىىف   4   ٔ   8    ٔ  12   تباىىةلإا ذىىعب  .  تىىبقاشي ٔ ىيىىياح ىىىح
ا لإ  واذخخساب لإيشفناب تباةلإا ذض تيعاًُنا تبااخس تيجاشخلإا دإًنا   ن  ٍع تغنابنا ِدٔذه
قيشط   اضينلإا سابخخا  .   ٍيبٕىهجًٕيٓنا ٖٕىخحي ىواشىًحنا بوذىنا ثاشىك دذىع ىيىياح ىىح كنزك
ٔ نا  بوذنا ايلاخن ٗعُٕنا ٔ ٗه نا دذع   تىساسذنا ةشخف للاخ واضيبنا  .  ىضٔ     اضىينلإا ساىبخخا
 ذىُع تباىىصًنا بىَاساا ٗىف تىىيعاُي واىسجا دٕىجٔ  ٕبىساا     تىىيهًعًنا ٖٔذىعنا ٍىي َٗاىىثناNour El Din H. Sherif et al  
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تىىيًْ  جىىبثي اىىي ٕىىْٔ   اىىبخخا اضىىينلإا س      يخىىشخنا ٗىىف   ٖٔذىىعهن شىىب بًنا  .  ٖٕخىىسي مىىةٔ
تباىىةاا ذىىىعب شىىشاعنا  ٕبىىىساا اىىف ةٔسزىىىنا ٗىىنص تىىىيعاًُنا واىىسجاا  .  ٗىىىنا تبىىسُناب اىىىيا
 تىىاناعًنا ثاىىعًٕاًنا    جىىَاك ذىىاف ثابااخىىسلاا    تٓباىىشي  لاىىعنا مىىبق تىىينٔاا تىىيعاًُنا
ثابااخىىسلا   تىىاناعًنا شىىيا ٔ تباىىصًنا بىىَاساا  . ىىاناعًنا ذىىعب ٍىى نٔ ىىف ت إ  ٌ ثابااخىىسلاا  
 تيعاًُنا ثشٓظ     ٗهع ثذًخعص اخنا ٔ ّيُٕعي ثافلاخخا نا شصُع جىقٕ   ٔ    ٗناىخناب  ةواىفك
تاناعًنا  .  ٔ   خي اًيف ب ثاسايانا    ذاف ىّيٕيذنا    تىساسذنا جحضٔ    ٌ    وذىنا ثاشىك داذىع
ح ذق ٍيبٕهجًٕيٓنا ٖٕخحي كنزك ٔ واشًحنا أ  بهسناب ثشث ( فيفط ود شاف  )  ثاَإيحنا ٗف
  تباصًنا   ٕبساا  ٍي تياذب 11    ٔ 12   انإخنا ٗهع ىتباةلإا ذعب  .  ذق ٔ ازْ   لاعنا  ُي
تيٕيذنا ثاشييغخنا ِزْ ش بًنا  .  َّا ٗنا تساسذنا شيشح ٔ  ّىظٕحهي ِداىيص اضيا كاُْ ٌاك
  دذعا ٗف ضًحهن تبحًنا ثاش نا   ىخنا ٔ ٗ     ٕبىساا اىف ةٔسزىنا جىغهبٔ 4    ٔا 6     بمىك اىف
ثاعًٕاًنا  . انا ٍ ًي ٗناخناب ٔ  داذىعا ةداىيص ٔ وذىنا شىاف ٍي مك ٌاب لٕ  تىبحًنا ثاشى نا
ضًحهن    ةضيًًنا ثاًسنا ٍي ٌإَ ي ذق تباةبن     ًايهًعي لإيشافناب .  
 